Drug Profile
Research programme: siRNA therapeutics - Chugai Pharmaceuticals/NanoCarrier
Alternative Names: Active-NanoFect siRNA - Chugai Pharmaceuticals/NanoCarrierLatest Information Update: 28 Nov 2021
Price :
$50
*
At a glance
- Originator Chugai Pharmaceutical; NanoCarrier
- Class Small interfering RNA
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Nov 2021 No recent reports of development identified for research development in Unspecified in Japan
- 25 Oct 2017 Early research in Undefined indication in Japan before October 2017 (Nano Carrier pipeline, October 2017)